Neumora Therapeutics, Inc. Common Stock

of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Corporate Presentation dated January 2026 104 Cover Page Interactive Data File (emb